What is Tyra Biosciences, Inc.'s operating lease liabilities?

Tyra Biosciences, Inc. (TYRA) reported operating lease liabilities of $5.21M in Q1 2026.

How has Tyra Biosciences, Inc.'s operating lease liabilities changed year-over-year?

Tyra Biosciences, Inc.'s operating lease liabilities decreased by 8.5% year-over-year, from $5.7M to $5.21M.

What does operating lease liabilities mean?

Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Tyra Biosciences, Inc. TYRA Operating Lease Liabilities

Operating Lease Liabilities at other companies

BridgeBio PharmaBBIO

$14.22M+189%

ArriVent BioPharma, Inc.AVBP

$320K—

Nuvation BioNUVB

$2.2M-42.7%

Bicara TherapeuticsBCAX

$301K—

Cogent Biosciences, Inc.COGT

$14.1M-8.9%

Cullinan Therapeutics, Inc.CGEM

$1.66M+236%

Other financials

Income statement

See full

Operating income-$42.0M-31.9%

Net income-$39.3M-39.6%

EPS (diluted)-$0.64-36.2%

Balance sheet

See full

Cash & equivalents$85.0M-15.7%

Total debt$5.7M-6.9%

Total equity$387.6M+19.8%

Total assets$412.0M+20.0%

Cash flow

See full

Operating cash flow-$32.6M-27.9%

CapEx$88.0K+529%

Free cash flow-$32.7M-28.2%

Valuation

See full

Market cap$1.81B+318%

Enterprise value$1.73B+397%

Returns & leverage

See full

Return on equity-36.9%+21.1pp

Debt / equity0×0.0×

Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s operating lease liabilities?: Tyra Biosciences, Inc. (TYRA) reported operating lease liabilities of $5.21M in Q1 2026.
How has Tyra Biosciences, Inc.'s operating lease liabilities changed year-over-year?: Tyra Biosciences, Inc.'s operating lease liabilities decreased by 8.5% year-over-year, from $5.7M to $5.21M.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.